Medical Digest & Congress Report

Prof. Evelien Dekker highlights key updates in screening and surveillance protocols for colorectal cancer prevention at the UEG Week 2026 Congress. This brief examines the practical application of the new European guidelines, discussing evidence-based recommendations to optimize risk stratification, refine post-polypectomy surveillance, and enhance quality standards in clinical practice to reduce cancer incidence and mortality.

Video: https://medicaldigest.org/scientific-contents/interview:preventing-colorectal-cancer-using-new-european-guidelines

Dr. David Martí-Aguado addresses the clinical challenges surrounding metabolic dysfunction-associated steatohepatitis (MASH) and progressive liver fibrosis at the UEG Week 2026 Congress. This brief outlines the expanding burden of MASH in gastroenterology practice, emphasizing early risk stratification, non-invasive diagnostic strategies, and the emergence of targeted disease-modifying therapies designed to halt or reverse fibrotic progression.

Video: https://medicaldigest.org/scientific-contents/interview:mash-liver-fibrosis-growing-burden-targeted-treatment

Dr. Naim Alkhouri highlights the critical central role of the liver in cardiometabolic health at the UEG Week 2026 Congress. This brief explores the complex intersections between obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), and MASH, providing gastroenterologists with actionable strategies for early identification, integrated care workflows, and modern therapeutic options to improve long-term outcomes across GI practice.

Video: https://medicaldigest.org/scientific-contents/interview:liver-metabolic-hub-connecting-obesity-masldmash-and-gi-practice

Dr. Christopher Ma presents actionable insights on advancing clinical care in Crohn’s disease at the UEG Week 2026 Congress. This brief explores updated management algorithms, emphasizing risk stratification, proactive monitoring, and timely optimization of biologic and novel targeted therapies to achieve durable disease control and improve long-term outcomes for patients with Crohn's disease.

Video: https://medicaldigest.org/scientific-contents/interview:refining-strategies-management-crohns-disease

Dr. Manuel Barreiro de Acosta shares key perspectives on navigating the modern therapeutic landscape in ulcerative colitis at the UEG Week 2026 Congress. Focusing on the IL-23 pathway, this brief highlights clinical data and strategic considerations for incorporating IL-23 targeted therapies to achieve durable endoscopic remission and set new standards in patient-centered IBD care.

Video: https://medicaldigest.org/scientific-contents/interview:il-23-orbit-guiding-ulcerative-colitis-care-towards-new-frontier

Prof. Remo Panaccione highlights modern therapeutic strategies in inflammatory bowel disease at the UEG Week 2026 Congress. This brief examines the evolving roles of advanced targeted agents, focusing on the clinical utility of novel JAK inhibitors and IL-23 targeted therapies to achieve deep disease control, optimize long-term patient outcomes, and personalize treatment pathways in IBD.

Video: https://medicaldigest.org/scientific-contents/interview:modern-treatment-principles-ibd-jak-inhibitors-and-il-23-targeted-therapies

Prof. Jean-Frédéric Colombel presents key insights on optimizing therapeutic outcomes in ulcerative colitis at the UEG Week 2026 Congress. Drawing from the latest data from the VERDICT trial, this brief explores the clinical rationale for targeting deep endoscopic and histological healing, highlighting strategies to elevate treatment standards, prevent long-term bowel damage, and achieve sustained remission for patients with IBD.

Video: https://medicaldigest.org/scientific-contents/interview:time-verdict-advancing-future-ulcerative-colitis-through-optimal-control

Dr. Caterina Conte presents key takeaways from the EASD e-Learning expert session on obesity at the EASD 2026 Congress. This brief highlights clinical strategies for comprehensive weight management, addressing metabolic comorbidities, and utilizing evidence-based educational frameworks to optimize patient care.

Video: https://medicaldigest.org/scientific-contents/interview:easd-e-learning-expert-session-modern-approaches-obesity-management

Dr. Åke Sjöholm presents key insights from the EASD-ESC joint session on advancing cardiovascular protection with incretins and SGLT-2 inhibitors at the EASD 2026 Congress. This brief highlights clinical mechanisms, cardiorenal benefits, and combined therapeutic strategies to reduce cardiovascular risk and improve outcomes in patients with metabolic disease and type 2 diabetes.

Video: https://medicaldigest.org/scientific-contents/interview:advancing-cardiovascular-protection-incretins-and-sglt-2-inhibitors-easd-esc-joint-session

Dr. Eric Lawitz presents a hepatologist's perspective on altering the trajectory of chronic metabolic disease at the EASD 2026 Congress. This brief highlights the evolving role of GLP-1-based therapies and strategies for integrating targeted liver health management beyond simple steatosis into comprehensive metabolic care.

Video: https://medicaldigest.org/scientific-contents/interview:changing-trajectory-chronic-metabolic-disease-hepatology-perspective-glp-1-care-integrating-liver-health-beyond-steatosis